Single fluorine substituted methyl ether preparation method

A monofluoromethyl ether, fluorinated technology, applied in the field of preparation of monofluoromethyl ether, can solve the problem of low reaction conversion rate

Inactive Publication Date: 2006-02-15
SHANDONG NEWTIME PHARMA
View PDF10 Cites 7 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0006] In addition, U.S. Patent No. 4,874,901 reported that under the condition of high temperature and high pressure, chloromethyl 2,2,2-trifluoro-1-(trifluoromethyl)ethyl ether reacted with pure potassium fluoride, but the reaction conversion rate was relatively low. Low

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Single fluorine substituted methyl ether preparation method
  • Single fluorine substituted methyl ether preparation method
  • Single fluorine substituted methyl ether preparation method

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0025] Add 168g of hexafluoroisopropanol, 11.3g of boron trifluoride etherate complex and 90g of paraformaldehyde into a 250mL single-necked bottle equipped with a magnetic stirring and reflux device, heat and reflux for 5 hours, and after the reaction is completed, 186g is obtained by distillation. According to GC analysis, it contains 90.5% of sevoflurane, and the yield is 84%.

Embodiment 2

[0027] Add 168g of hexafluoroisopropanol, 6.7g of anhydrous aluminum trifluoride, 120mL of chloroform and 90g of paraformaldehyde into a 500mL single-necked bottle with a magnetic stirring and reflux device, heat and reflux for 5 hours, and after the reaction is complete, distill to obtain 164g , containing sevoflurane 88.2% by GC analysis, yield: 72%.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention provides a process for preparing monofluoromethyl ether, especially fluoromethyl-2,2,2-trifluoro-1-(trifluoromethyl) ethyl ether (sevoflurane), wherein its precursor hexafluoroisopropanol is reacted with trioxymethylene at the presence of fluoro-containing catalyst.

Description

technical field [0001] The present invention relates to a method for preparing monofluoromethyl ether, especially fluoromethyl-2,2,2-trifluoro-1-(trifluoromethyl)ethyl ether (sevoflurane). technical background [0002] In recent years it has been discovered that fluorinated ethers are effective inhalational anesthetics. Included among these anesthetics is desflurane (CF 3 CHFOCHF 2 ), isoflurane (CF 3 CHClOCHF 2 ), enflurane (ClFCHCF 2 OCHF 2 ) and sevoflurane ((CF 3 ) 2 CHOCH 2 F). Sevoflurane is a particularly advantageous inhalational anesthetic because of its rapid loss of consciousness and rapid recovery—ideal properties of contemporary inhalational anesthetics. Sevoflurane is delivered to an air-breathing warm-blooded animal through the inhalation route at about 1% to 5% by volume in a mixture with oxygen or in a gaseous mixture containing sufficient oxygen to maintain respiration. [0003] U.S. Patents US3683092 and US3689571 disclose the use of sevoflurane...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): C07C43/12C07C41/01
CPCC07C41/01C07C43/123
Inventor 赵志全彭立增提文利
Owner SHANDONG NEWTIME PHARMA
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap